X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs TORRENT PHARMA - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. TORRENT PHARMA WOCKHARDT LTD./
TORRENT PHARMA
 
P/E (TTM) x -18.4 29.7 - View Chart
P/BV x 3.0 5.6 53.6% View Chart
Dividend Yield % 1.1 1.0 113.0%  

Financials

 WOCKHARDT LTD.   TORRENT PHARMA
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
TORRENT PHARMA
Mar-17
WOCKHARDT LTD./
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1,1291,768 63.9%   
Low Rs6271,186 52.9%   
Sales per share (Unadj.) Rs363.1346.1 104.9%  
Earnings per share (Unadj.) Rs-20.455.2 -37.1%  
Cash flow per share (Unadj.) Rs-7.073.3 -9.5%  
Dividends per share (Unadj.) Rs10.0014.00 71.4%  
Dividend yield (eoy) %1.10.9 120.1%  
Book value per share (Unadj.) Rs301.8257.1 117.4%  
Shares outstanding (eoy) m110.55169.22 65.3%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.44.3 56.7%   
Avg P/E ratio x-42.926.8 -160.4%  
P/CF ratio (eoy) x-125.920.1 -624.9%  
Price / Book Value ratio x2.95.7 50.6%  
Dividend payout %-48.925.4 -192.7%   
Avg Mkt Cap Rs m97,063249,887 38.8%   
No. of employees `0006.811.8 57.4%   
Total wages/salary Rs m9,6659,934 97.3%   
Avg. sales/employee Rs Th5,931.84,971.5 119.3%   
Avg. wages/employee Rs Th1,428.1843.2 169.4%   
Avg. net profit/employee Rs Th-334.0792.4 -42.1%   
INCOME DATA
Net Sales Rs m40,14658,569 68.5%  
Other income Rs m1,1432,233 51.2%   
Total revenues Rs m41,28960,802 67.9%   
Gross profit Rs m12813,773 0.9%  
Depreciation Rs m1,4893,069 48.5%   
Interest Rs m2,2532,056 109.6%   
Profit before tax Rs m-2,47210,881 -22.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-2111,545 -13.7%   
Profit after tax Rs m-2,2609,336 -24.2%  
Gross profit margin %0.323.5 1.4%  
Effective tax rate %8.514.2 60.2%   
Net profit margin %-5.615.9 -35.3%  
BALANCE SHEET DATA
Current assets Rs m46,16053,841 85.7%   
Current liabilities Rs m19,25831,612 60.9%   
Net working cap to sales %67.038.0 176.6%  
Current ratio x2.41.7 140.7%  
Inventory Days Days10197 103.7%  
Debtors Days Days9484 112.3%  
Net fixed assets Rs m40,16542,079 95.5%   
Share capital Rs m553846 65.3%   
"Free" reserves Rs m32,81442,655 76.9%   
Net worth Rs m33,36743,501 76.7%   
Long term debt Rs m31,90322,408 142.4%   
Total assets Rs m89,687101,250 88.6%  
Interest coverage x-0.16.3 -1.5%   
Debt to equity ratio x1.00.5 185.6%  
Sales to assets ratio x0.40.6 77.4%   
Return on assets %011.3 -0.1%  
Return on equity %-6.821.5 -31.6%  
Return on capital %-0.319.6 -1.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,12120,066 45.5%   
Fx outflow Rs m2,1335,304 40.2%   
Net fx Rs m6,98814,762 47.3%   
CASH FLOW
From Operations Rs m-2,69510,127 -26.6%  
From Investments Rs m-6,863-7,869 87.2%  
From Financial Activity Rs m12,545-1,918 -654.1%  
Net Cashflow Rs m3,010212 1,423.3%  

Share Holding

Indian Promoters % 74.5 71.5 104.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 7.0 32.8%  
FIIs % 7.7 12.6 61.1%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 8.8 175.0%  
Shareholders   67,757 26,511 255.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   MERCK LTD  STERLING BIOTECH  ASTRAZENECA PHARMA  VENUS REMEDIES  IPCA LABS  

Compare WOCKHARDT LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Jan 22, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 8-QTR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS